Therapeutic Drug Monitoring of Naltrexone and 6β-Naltrexol During Anti-craving Treatment in Alcohol Dependence: Reference Ranges-Reference-Cited by-同舟云学术

Therapeutic Drug Monitoring of Naltrexone and 6β-Naltrexol During Anti-craving Treatment in Alcohol Dependence: Reference Ranges

Published:2018-09-27 Issue:1 Volume:54 Page:51-55
ISSN:0735-0414
Container-title:Alcohol and Alcoholism
language:en
Short-container-title:

Author:

Brünen Sonja¹,Bekier Nina Kim²,Hiemke Christoph¹,Korf Felix³,Wiedemann Klaus⁴,Jahn Holger⁵,Kiefer Falk²

Affiliation:

1. Department of Psychiatry and Psychotherapy, University of Mainz, Germany

2. Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Germany

3. Psychiatric Hospital Scivias St. Valentinushaus Bad Soden, Bad Soden, Germany

4. Department of Psychiatry and Psychotherapy, University of Hamburg, Germany

5. AMEOS Klinikum Heiligenhafen, Heiligenhafen, Germany

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/alcalc/article-pdf/54/1/51/27440291/agy067.pdf

Reference40 articles.

1. The obsessive compulsive drinking scale: a selfrated instrument for the quantification of thoughts about alcohol and drinking behavior;Anton;Alcohol Clin Exp Res,1995

2. An evaluation of muopioid receptor (OPRM1) as apredictor of naltrexone response in the treatment of alcohol: results from the combined pharmacotherapies and behavioral interventions for alcohol dependence (COMBINE) study;Anton;Arch Gen Psychiatry,2008

3. ABC of mental health: addiction and dependence-II;Ashworth;Alcohol BMJ,1997

4. Comparison of naltrexone and 6β-naltrexol for narcotic antagonist action in rats and mice;Blumberg;Fed Proc,1976

5. Carbonyl reduction of naltrexone and dolasetron by oxidoreductases isolated from human liver cytosol;Breyer-Pfaff;J Pharm Pharmacol,2004

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Roles of Endogenous D2R Dopamine and μ-opioid Receptors of the Brain in Alcohol Use Disorder;Current Medicinal Chemistry;2023-10-26

2. Bioresponsive nanostructured systems for sustained naltrexone release and treatment of alcohol use disorder: Development and biological evaluation;International Journal of Pharmaceutics;2020-07

3. Therapeutic Drug Monitoring and the Clinical Significance of Naltrexone Blood Levels at the Time of a First Drink: Relevance to the Sinclair Method;Alcohol and Alcoholism;2019-03-01